TY - JOUR
T1 - Common coding variant in SERPINA1 increases the risk for large artery stroke
AU - Malik, Rainer
AU - Dau, Therese
AU - Gonik, Maria
AU - Sivakumar, Anirudh
AU - Deredge, Daniel J
AU - Edeleva, Evgeniia V
AU - Götzfried, Jessica
AU - van der Laan, Sander W
AU - Pasterkamp, Gerard
AU - Beaufort, Nathalie
AU - Seixas, Susana
AU - Bevan, Steve
AU - Lincz, Lisa F
AU - Holliday, Elizabeth G
AU - Burgess, Annette I
AU - Rannikmäe, Kristiina
AU - Minnerup, Jens
AU - Kriebel, Jennifer
AU - Waldenberger, Melanie
AU - Müller-Nurasyid, Martina
AU - Lichtner, Peter
AU - Saleheen, Danish
AU - Rothwell, Peter M
AU - Levi, Christopher
AU - Attia, John
AU - Sudlow, Cathie L M
AU - Braun, Dieter
AU - Markus, Hugh S
AU - Wintrode, Patrick L
AU - Berger, Klaus
AU - Jenne, Dieter E
AU - Dichgans, Martin
N1 - Funding Information:
Samples were processed in the Genetics Core Laboratory of the WT Clinical Research Facility, Edinburgh. Neuroimaging was performed at the Scottish Funding Council Brain Imaging Research Centre Division of Clinical Neurosciences, University of Edinburgh, a core area of the WT Clinical Research Facility and part of the Scottish Imaging Network, a Platform for Scientific Excellence collaboration. This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of investigators who contributed to the generation of the data is available (https://www.wtccc.org.uk/). This work was supported by grants from the German Federal Ministry of Education and Research (e:Med program e:AtheroSysMed), the FP7 European Union (EU) project CVgenes{at}target(261123), the Deutsche Forschungsgemeinschaft (DFG) (CRC 1123, B3), the Corona Foundation, and the Fondation Leducq (Transatlantic Network of Excellence on the Pathogenesis of Small Vessel Disease of the Brain) (all to M.D.), as well as by grants from the Australian National and Medical Health Research Council (Grant 569257), Australian National Heart Foundation (NHF; Grant G 04S 1623), Gladys M. Brawn Fellowship scheme, and Vincent Fairfax Family Foundation in Australia. E.G.H. was supported by a Fellowship from the NHF and National Stroke Foundation of Australia (Grant 100071). The Wellcome Trust (WT) Case Control Consortium 2 (WTCCC2) was funded by the WT (WTCCC2 Projects 085475/B/08/Z, 085475/Z/08/Z, and WT084724MA). The Stroke Association provided support for collection of some of the St. George's Hospital cases. H.S.M. is supported by a National Institute for Health Research (NIHR) Senior Investigator Award and by the Cambridge University Hospitals National Health Service Trust NIHR Comprehensive Biomedical Research Centre. The work of H.S.M. and S.B. is supported by the Evelyn Trust. The Oxford cases were collected as part of the Oxford Vascular Study (funded by the Medical Research Council, Stroke Association, Dunhill Medical Trust, NIHR, and Biomedical Research Centre, Oxford). The Edinburgh Stroke Study was supported by the WT (clinician scientist award to C.L.M.S.) and the Binks Trust. Additional funding for this study was provided by the WT (Awards 076113 and 090355), a joint DFG grant (JE194/4-1 and BR 2152/2-1), the EU Horizon 2020 research and innovation program [Grant Agreement 668036, relapses prevention (RELENT)], and the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (Grant SOP1841-IQB2014).
PY - 2017
Y1 - 2017
N2 - Large artery atherosclerotic stroke (LAS) shows substantial heritability not explained by previous genome-wide association studies. Here, we explore the role of coding variation in LAS by analyzing variants on the HumanExome BeadChip in a total of 3,127 cases and 9,778 controls from Europe, Australia, and South Asia. We report on a nonsynonymous single-nucleotide variant in serpin family A member 1 (SERPINA1) encoding alpha-1 antitrypsin [AAT; p.V213A; P = 5.99E-9, odds ratio (OR) = 1.22] and confirm histone deacetylase 9 (HDAC9) as a major risk gene for LAS with an association in the 3'-UTR (rs2023938; P = 7.76E-7, OR = 1.28). Using quantitative microscale thermophoresis, we show that M1 (A213) exhibits an almost twofold lower dissociation constant with its primary target human neutrophil elastase (NE) in lipoprotein-containing plasma, but not in lipid-free plasma. Hydrogen/deuterium exchange combined with mass spectrometry further revealed a significant difference in the global flexibility of the two variants. The observed stronger interaction with lipoproteins in plasma and reduced global flexibility of the Val-213 variant most likely improve its local availability and reduce the extent of proteolytic inactivation by other proteases in atherosclerotic plaques. Our results indicate that the interplay between AAT, NE, and lipoprotein particles is modulated by the gate region around position 213 in AAT, far away from the unaltered reactive center loop (357-360). Collectively, our findings point to a functionally relevant balance between lipoproteins, proteases, and AAT in atherosclerosis.
AB - Large artery atherosclerotic stroke (LAS) shows substantial heritability not explained by previous genome-wide association studies. Here, we explore the role of coding variation in LAS by analyzing variants on the HumanExome BeadChip in a total of 3,127 cases and 9,778 controls from Europe, Australia, and South Asia. We report on a nonsynonymous single-nucleotide variant in serpin family A member 1 (SERPINA1) encoding alpha-1 antitrypsin [AAT; p.V213A; P = 5.99E-9, odds ratio (OR) = 1.22] and confirm histone deacetylase 9 (HDAC9) as a major risk gene for LAS with an association in the 3'-UTR (rs2023938; P = 7.76E-7, OR = 1.28). Using quantitative microscale thermophoresis, we show that M1 (A213) exhibits an almost twofold lower dissociation constant with its primary target human neutrophil elastase (NE) in lipoprotein-containing plasma, but not in lipid-free plasma. Hydrogen/deuterium exchange combined with mass spectrometry further revealed a significant difference in the global flexibility of the two variants. The observed stronger interaction with lipoproteins in plasma and reduced global flexibility of the Val-213 variant most likely improve its local availability and reduce the extent of proteolytic inactivation by other proteases in atherosclerotic plaques. Our results indicate that the interplay between AAT, NE, and lipoprotein particles is modulated by the gate region around position 213 in AAT, far away from the unaltered reactive center loop (357-360). Collectively, our findings point to a functionally relevant balance between lipoproteins, proteases, and AAT in atherosclerosis.
KW - antitrypsin
KW - genetics
KW - ischemic stroke
KW - large artery stroke
KW - variation
U2 - 10.1073/pnas.1616301114
DO - 10.1073/pnas.1616301114
M3 - Article
C2 - 28265093
SN - 0027-8424
VL - 114
SP - 3613
EP - 3618
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 14
ER -